title: Vaccination in paediatric rheumatology.
abstract: As awareness of the risk of vaccine-preventable diseases for children with rheumatic diseases has increased, vaccination has become an important clinical consideration and focus of research in paediatric rheumatology. Conflicting reports in the literature and differing advice from national bodies regarding the safety of different vaccines for this patient population have led to confusion in the minds of many rheumatologists as to what is appropriate. This article will provide an overview of crucial aspects of the recently published European League Against Rheumatism recommendations regarding vaccination of paediatric patients with rheumatic disease, and will review advances in this field since their publication.
authors.affiliation: Rheumatology Unit, Department of General Medicine, Royal Children's Hospital (RCH), 50 Flemington Road, Parkville, 3052, Melbourne, Victoria, Australia, Jonathan.Akikusa@rch.org.au.
authors.forename: Jonathan D
authors.initials: JD
authors.lastname: Akikusa
authors.forename: Nigel W
authors.initials: NW
authors.lastname: Crawford
mesh_terms: D002648:Child; D006801:Humans; D016867:Immunocompromised Host; D007252:Influenza Vaccines; D022542:Measles-Mumps-Rubella Vaccine; D009894:Opportunistic Infections / Q000150:complications* / Q000276:immunology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines; D017410:Practice Guidelines as Topic; D012216:Rheumatic Diseases / Q000150:complications* / Q000276:immunology; D014611:Vaccination; D014613:Vaccines, Attenuated
chemical_list: D007252:Influenza Vaccines; D022542:Measles-Mumps-Rubella Vaccine; D053918:Papillomavirus Vaccines; D014613:Vaccines, Attenuated